Steven Cohen Bristol Myers Squibb CO Put Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $14,393 - $16,320	-300 Reduced 12.5%	2,100 $113,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $3.2 Million - $3.55 Million	-50,200 Reduced 95.44%	2,400 $153,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $3.5 Million - $3.96 Million	-53,200 Reduced 50.28%	52,600 $3.65 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2.31 Million - $2.73 Million	33,700 Added 46.74%	105,800 $7.61 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $9,373 - $5.54 Million	72,100 New	72,100 $5.13 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $54.8 Million - $64.1 Million	1,000,000 New	1,000,000 $58.8 Million

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.